hsa-mir-3074: Hsa-mir-3074 is a microRNA that has been identified in breast cancer luminal B and has been associated with papillary renal cell carcinoma [PMC5123339]. However, its role in breast cancer is not yet known [PMC5123339]. Hsa-mir-3074, along with hsa-mir-25 and hsa-mir-106b, has been found to be involved in DNA damage response pathways [PMC9998480]. In prostate cancer, hsa-mir-3074 is one of the 22 upregulated microRNAs that can predict gene expression regulation [PMC8426106]. Hsa-mir-3074 has also been identified as a potential prognostic marker for esophageal adenocarcinoma [PMC6956414]. However, the function of hsa-mir-3074 in carcinogenesis is not well understood and requires further investigation [PMC6661144]. No target gene for hsa-mir-3074 has been predicted so far [PMC6661144]. In triple-negative breast cancer, hsa-miR-301b, hsa-miR-183, hsa-miR-18a, and hsa-miR-96 are upregulated compared to adjacent non-tumor tissue [PMC7499949]. Overall, the role of hsa-mir-3074 in different types of cancer is still being explored and further research is needed to fully understand its function and potential as a therapeutic target [PMC6661144].